AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS …

duration of diabetes, presence of comorbidities, diabetic complications, and hypoglycemia risk • Fied regimen Increase TDD by 2 U • Adustable regimen • FBG 180 mg/dL add 20 of TDD • FBG 140180 mg/dL add 10 of TDD • TDD 0.30.5 U/gFBG 110139 mg/dL add 1 unit • If hypoglycemia reduce TDD by • BG 0 mg/dL 10 20 • BG 40 mg/dL 20 40

  Diabetes, Complications

| American Association of Clinical Endocrinology

History Exam Laboratory Diagnostic procedures Risk calculators Ill. Screening for and Assessing Lipid Disorders and ASCVD Risk Personal: smoking, diet, physical activity, impaired glucose tolerance, metabolic syndrome, diabetes, obesity,

Initiating and Intensifying Insulin Therapy in Patients ...

control and preserve beta-cell function in patients with newly diagnosed T2D and severe, symptomatic hyperglycemia. 1-3 • By treating patients with insulin before diabetes has progressed (typically for 2 weeks to 3 months), glucolipotoxicity is rapidly reversed, and beta -cells are given the chance to “rest.” 1-3

  Patients, Diabetes, Inpa tient

AMERICAN ASSOCIATION OF CLINICAL …

crosses medical, social, and economic lines. These guide-lines have been developed by the American Association of Clinical Endocrinologists (AACE) with hopes of reduc-ing the risk of osteoporosis-related fractures and thereby maintaining the quality of life for people with osteopo-rosis. The guidelines use the best evidence, taking into

  American, Guide, Clinical, Association, American association of clinical, Aace, American association of clinical endocrinologists, Endocrinologists

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION …

achieve treatment goals. When targeting triglyceride levels, the desirable goal is <150 mg/dL. Statin therapy should be combined with a fibrate, prescription-grade omega-3 fatty acid, and/or niacin to reduce triglycerides in all patients with triglycerides ≥500 …

  Therapy, Triglyceride

IV Insulin for Hospitalized Patients

hospitalized patients has led to updates in clinical practice guidelines1 • Several published guidelines address the management of hyperglycemia in hospitalized patients, in both critical and non-critical settings2-7 1. Lansang MC, et al. Cleve Clin J Med. 2016;83(5 Suppl 1):S34-S43. 2. Qaseem A, et al. Am J Med Qual. 2014;29(2):95-98. 3.

  Patients, Management, Hyperglycemia, Hospitalized, Management of hyperglycemia in hospitalized patients, Hospitalized patients

ESC/EAS Guidelines for the management of dyslipidemias

4D Die Deutsche Diabetes Dialyse Studie 4S Scandinavian Simvastatin Survival Study ABC-1 ATP-binding cassette transporter 1 ACCORD Action to Control Cardiovascular Risk in Diabetes ACS acute coronary syndrome AIM-HIGH Atherothrombosis Intervention in Metabolic syndrome with Low HDL-C/High Triglyceride and Impact on Global Health Outcomes

  Guidelines, Management, Diabetes, Eas guidelines for the management of

Lipid Testing - Quest Diagnostics

•Secondary dyslipidemia, including diabetes mellitus, disorders of gastrointestinal absorption, chronic renal failure •Signs or symptoms of dyslipidemias, such as skin lesions •As follow-up to the initial screen for coronary heart disease (total cholesterol + …

  Quest diagnostics, Quest, Diagnostics, Diabetes, Dyslipidemia

PREDIABETES

Prediabetes Centers for Disease Control, 2012 37% (86 million) U.S. adults aged 20 years or older have prediabetes1 o Percentage was similar by race o 51% aged ≥65 years Only 11% were aware they had it2 In adolescents aged 12 to 19 years, prevalence of prediabetes and diabetes increased from 9% to 23%3 1. National Diabetes Statistics Report

  Diabetes, Prediabetes

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION …

X. Profiles of Medications for Dyslipidemia I. Dyslipidemic States Dyslipidemia comprises a range of conditions, primarily defined by elevations in lipoprotein choles-terol, including LDL-C and non-high-density lipoprotein cholesterol (HDL-C), as well as elevated triglycerides (see Dyslipidemia and Prevention of Cardiovascular Disease

  Dyslipidemia